GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
V

ViewRay VRAYQ · USD

Health Care · US listing · 🇺🇸 United States

Compare

0.00

—

Close of 9 Nov 2026, in USD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

Price performance

Chart by TradingView, with its own licensed prices

ViewRay — daily VRAYQ Delayed
Market value
$183
Last close × shares
Volume
1.1k
Shares, 9 Nov 2026

About ViewRay

Its shares trade under the ticker VRAYQ. It has been listed since 4 November 2014. In the fiscal year to 31 December 2022, it reported revenue of $102.2m and a net loss of $107.3m. At that date it held total assets of $271.4m and shareholders' equity of $82.2m.

ViewRay, Inc. designs, manufactures and markets magnetic resonance imaging (MRI) system. The company is headquartered in Oakwood Village, Ohio. The company went IPO on 2014-11-04. The MRIdian is a system that integrates high quality radiation therapy with simultaneous magnetic resonance imaging (MRI). The company provides two generations of the MRIdian: the first generation MRIdian with Cobalt-60 based radiation beams and the second generation MRIdian Linac, with linear accelerator (linac) based radiation beams. The MRIdian combines MRI and external-beam radiation therapy to simultaneously image and treat cancer patients. MRIdian also records the level of radiation dose that the treatment area has received. MRIdian system is comprised of three components: the MRI system, the radiation delivery system and an integrated treatment planning and delivery software. The MRI system is the component of MRIdian that captures soft tissue images of the patient’s body. Its MRI system captures and displays live images in one plane, four times per second or in three planes, two times per second.

Figures and description from our data supplier, not checked against the company's own report.

More about ViewRay →

Latest on ViewRay

Our reporting

We have not reported on ViewRay yet.

Next results

2 Mar 2027

Due on 2 Mar 2027. Analysts expect earnings of -0.17 a share.

Other Health Care listings

Scenario calculator

Try your own numbers. This is arithmetic, not a forecast.

Interactive

Gain or loss

—

Return

—

Leaves out fees, taxes and financing.

Frequently asked questions

What is ViewRay's ticker?

ViewRay trades as VRAYQ on its US listing, under ISIN US92672L1070.

What was ViewRay's last closing price?

0.00 on 9 Nov 2026. The figure is in USD and is never converted.

When does ViewRay next report results?

Results are expected on 2 Mar 2027, according to our data supplier.

Sources and methodology

Chart
TradingView
Close and company data
Our data supplier
News
Our reporting

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.